Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? (Q42215146)

18 October 2017

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? (English)

1 reference

18 October 2017

1 reference

1 reference

cognitive dysfunction

1 reference

6

Agid Y

1 reference

18 October 2017

Pillon B

1

1 reference

18 October 2017

Dubois B

2

1 reference

18 October 2017

Cusimano G

3

1 reference

18 October 2017

Bonnet AM

4

1 reference

18 October 2017

Lhermitte F

5

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

18 October 2017

1 reference

18 October 2017

52

1 reference

18 October 2017

201-206

1 reference

18 October 2017

2

1 reference

Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Parkinsonism: onset, progression, and mortality

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Levodopa's awakening effect on patients with Parkinsonism

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

A subcortico-cortical cholinergic system is affected in Parkinson's disease.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Intellectual functioning of persons with idiopathic Parkinsonism.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Intellectual impairment in Parkinson's syndrome

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Psychiatric disturbances in Parkinson's disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

The heterogeneity of Parkinson's disease: clinical and prognostic implications.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Cholinergic-dependent cognitive deficits in Parkinson's disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

A modified card sorting test sensitive to frontal lobe defects

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Levodopa, parkinsonism, and recent memory

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Levodopa and psychometric test performance in parkinsonism-5 years later

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Effects of anticholinergic drugs on memory in Parkinson's disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Dementia in Parkinson disease: a neuropsychological analysis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Cognitive deficits in the early stages of Parkinson's disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

Cortical cholinergic deficit in mentally impaired Parkinsonian patients

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032506

17 August 2018

1 reference

12 December 2020

1 reference

12 December 2020

Cognitive fluctuations associated with on-off phenomenon in Parkinson disease

1 reference

12 December 2020

Intellectual changes in patients with MPTP-induced parkinsonism

1 reference

12 December 2020

[The L-dopa test in Parkinson's disease]

1 reference

12 December 2020

Dementia in idiopathic Parkinson's disease. Variables associated with its occurrence in 203 patients

1 reference

12 December 2020

Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus

1 reference

12 December 2020

Predictive factors for cognitive deterioration and dementia in Parkinson's disease

1 reference

12 December 2020

Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.52.2.201

1 reference

18 October 2017

1 reference

18 October 2017

1 reference